All Releases
 |
Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
Jun 26, 2009
|
11.5 KB |
| |
GENEVA, and REDWOOD CITY, Calif., June 26, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported that the St. Gallen International Consensus Panel on the Primary Therapy of Early Breast Cancer recommended for the first time that validated multigene assays, such as Oncotype DX(R), should be conside...
|
|
Genomic Health Study Shows Breast Cancers in Men Display Very Similar Gene Signatures to Those in Women
May 29, 2009
|
12.3 KB |
| |
ORLANDO, Fla., May 29, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results from a study which summarized the gene signatures identified by the Oncotype DX(R) breast cancer test in a large number of male patients for whom the test was used to guide treatment with chemotherapy. The result...
|
|
Oncotype DX® Guides Individualized Treatment Decisions for More than 100,000 Breast Cancer Patients Worldwide
May 28, 2009
|
16.8 KB |
| |
REDWOOD CITY, Calif., May 28, 2009 – Genomic Health, Inc. (Nasdaq: GHDX) today announced an important milestone in reaching a total of more than 100,000 patients with its Oncotype DX® breast cancer test since the test became available in 2004. Oncotype DX is the first and only gene expression test clinically validated to predict the likelihood...
|
|
Genomic Health to Present Multiple New Studies at the American Society of Clinical Oncology Annual Meeting
May 21, 2009
|
9.8 KB |
| |
REDWOOD CITY, Calif., May 21, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will present results from three studies at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place May 29 - June 2, 2009, at the Orange County Convention Center in Orlando, F...
|
|
Genomic Health's Oncotype DX® Colon Cancer Test Predicts Individualized Recurrence Risk for Stage II Colon Cancer Patients
May 14, 2009
|
14.1 KB |
| |
REDWOOD CITY, Calif., May 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results from the landmark QUASAR validation study, which demonstrated that the Oncotype DX(R) colon cancer test can independently predict individual recurrence risk in stage II colon cancer patients follo...
|
|
Genomic Health to Present at JMP Securities Research Conference
May 13, 2009
|
7.5 KB |
| |
REDWOOD CITY, Calif., May 13, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Brad Cole, Genomic Health's Chief Operating and Financial Officer, will present at the Eighth Annual JMP Securities Research Conference in San Francisco, on Tuesday, May 19, 2009 at 11:00 a.m. PT.
To access ...
|
|
Genomic Health Announces First Quarter 2009 Financial Results and Business Progress
May 5, 2009
|
16.0 KB |
| |
REDWOOD CITY, Calif., May 5, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2009.
Total revenue increased to $33.9 million in the first quarter of 2009 compared with $23.4 million in the first quarter of 2008. Product ...
|
|
Genomic Health to Announce First Quarter 2009 Financial Results and Host Conference Call on Tuesday, May 5, 2009
Apr 28, 2009
|
7.9 KB |
| |
REDWOOD CITY, Calif., April 28, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, May 5, 2009 at 4:30 p.m. Eastern Time to discuss its first quarter 2009 financial results. The call and webcast will follow the release of th...
|
|
Genomic Health Announces Study Confirming Prognostic Value of Oncotype DX(R) Recurrence Score(R) Result in Japanese Breast Cancer Patients
Apr 20, 2009
|
11.0 KB |
| |
REDWOOD CITY, Calif. and KYOTO, Japan, April 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced results of a multi-center Japanese study demonstrating that the Oncotype DX breast cancer assay had significant prognostic value in Japanese women with estrogen receptor-positive early-stage bre...
|
|
Genomic Health Announces Positive Preliminary Results from QUASAR Validation Study of Oncotype DX(R) Colon Cancer Assay
Apr 14, 2009
|
11.1 KB |
| |
REDWOOD CITY, Calif., April 14, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the QUASAR validation study met its primary endpoint to predict the likelihood of recurrence for stage II colon cancer patients following surgery, and that the colon cancer Recurrence Score(R) provided add...
|
|
Genomic Health Announces Fourth Quarter and Year-End 2008 Financial Results and Business Progress, Provides 2009 Financial Guidance
Feb 3, 2009
|
18.9 KB |
| |
REDWOOD CITY, Calif., Feb 03, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health,
Inc. (Nasdaq: GHDX) today reported financial results and business progress for
the fourth quarter and year ended December 31, 2008.
Total revenue for the fourth quarter of 2008 increased to $31.2 million,
compared with $19.3 million in the fourt...
|
|
Genomic Health to Announce Fourth Quarter and Year-End 2008 Financial Results and Host Conference Call on Tuesday, February 3, 2009
Jan 27, 2009
|
7.9 KB |
| |
REDWOOD CITY, Calif., Jan 27, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the company will host a conference call and webcast on Tuesday, February 3, 2009 at 4:30 p.m. Eastern Time to discuss its fourth quarter and year-end 2008 financial results. The call and webcast will follow t...
|
|
Genomic Health Announces Commencement of QUASAR Clinical Validation Study for Oncotype DX(R) Colon Cancer Assay
Jan 12, 2009
|
12.6 KB |
| |
REDWOOD CITY, Calif., Jan 12, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- - Company to Provide Update on Pipeline Efforts at 27th Annual J.P. Morgan Healthcare Conference -
Genomic Health, Inc. (Nasdaq: GHDX) announced today that it has initiated an independent clinical validation study for its 18-gene Oncotype DX(R) colon cancer assay....
|
|
Genomic Health Announces Management Changes and New Responsibilities
Jan 8, 2009
|
10.7 KB |
| |
REDWOOD CITY, Calif., Jan 08, 2009 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health,
Inc. (Nasdaq: GHDX) today announced the appointment of Kimberly J. Popovits as
chief executive officer. Formerly president and chief operating officer,
Popovits is now the president and CEO of Genomic Health. In addition, G.
Bradley Cole has b...
|
|
Genomic Health Announces Study Establishing the Utility of Oncotype DX(R) in Node-Negative and Node-Positive Breast Cancer Patients Treated with Aromatase Inhibitors
Dec 13, 2008
|
14.6 KB |
| |
SAN ANTONIO, Dec 13, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc.
(Nasdaq: GHDX) today announced findings from a European study demonstrating
that the Oncotype DX Recurrence Score(R) result is a significant independent
predictor of distant recurrence in both node-negative and node-positive,
hormone receptor-positi...
|
|
Genomic Health Announces Appointment of Ginger Graham to Board of Directors
Dec 8, 2008
|
10.1 KB |
| |
REDWOOD CITY, Calif., Dec 08, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health,
Inc. (Nasdaq: GHDX) today announced the appointment of Ginger L. Graham to its
board of directors. Ms. Graham is the former President and CEO of Amylin
Pharmaceuticals, Inc.; a biopharmaceutical company dedicated to developing
innovative medici...
|
|
Genomic Health to Present Multiple New Studies at 31st Annual San Antonio Breast Cancer Symposium
Dec 5, 2008
|
10.2 KB |
| |
REDWOOD CITY, Calif., Dec 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health,
Inc. (Nasdaq: GHDX) today announced that the company will present results from
four studies at the 31st Annual San Antonio Breast Cancer Symposium, taking
place December 10-14, 2008, at the Henry B. Gonzalez Convention Center. Two
of the studie...
|
|
Genomic Health to Present at Stephens Fall Investment Conference
Nov 11, 2008
|
7.8 KB |
| |
REDWOOD CITY, Calif., Nov 11, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will present at the Stephens Fall Investment Conference in New York on Tuesday, November 18, 2008 at 11:00 a.m. ET.
To access the...
|
|
Genomic Health Announces Publication of a Study Demonstrating the Oncotype DX(R) Breast Cancer Assay Influences Chemotherapy Treatment Recommendation in 44 Percent of Patients Evaluated
Nov 10, 2008
|
11.3 KB |
| |
REDWOOD CITY, Calif., Nov 10, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced the publication of results from a study indicating that Oncotype DX(R) Recurrence Score(R) results impact the way physicians treat early-stage breast cancer. The study, published in the October issue of the Americ...
|
|
Genomic Health Announces Third Quarter 2008 Financial Results and Business Progress
Nov 5, 2008
|
17.3 KB |
| |
REDWOOD CITY, Calif., Nov 05, 2008 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended September 30, 2008.
Total revenue increased to $28.1 million in the third quarter of 2008 compared with $15.9 million in the third quarter of 2007. ...
|
|
|
